Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine

Area of Science:

• Immunology
• Cell Biology
• Histology

Background:

• Bromodeoxyuridine (BrdU) is a thymidine analog incorporated into DNA during the S-phase of the cell cycle.
• Accurate detection of BrdU is crucial for studying cell proliferation and DNA synthesis.
• Existing methods for BrdU detection may have limitations in specificity or require complex procedures.

Purpose of the Study:

• To develop and characterize a new monoclonal antibody for specific detection of BrdU.
• To establish a reliable double-labeling technique for co-localizing BrdU incorporation with cellular antigens.

Main Methods:

• Selection of a monoclonal antibody (Bu20a) against BrdU using the APAAP technique on human tissues.
• Evaluation of antibody specificity and cross-reactivity with normal nuclei.
• Development of a double-labeling protocol combining immunoperoxidase staining for cellular antigens with indirect immunofluorescence for BrdU detection.

Main Results:

• The Bu20a antibody specifically stains BrdU incorporated into nuclei across diverse cell types.
• No cross-reactivity was observed with normal nuclei, indicating high specificity.
• The double-labeling technique successfully co-localized BrdU incorporation with various cellular antigens (e.g., MHC class II, T-cell markers, keratin) in human and animal samples.

Conclusions:

• The Bu20a antibody is a valuable tool for detecting BrdU incorporation in various cell types and tissues.
• The described double-labeling technique facilitates the analysis of S-phase cell phenotypes and antigen expression patterns.
• This approach has broad applications in cell biology, immunology, and cancer research for understanding cell proliferation and tissue dynamics.